Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Trovagene Inc.
DescriptionMolecular diagnostic test to detect phosphoinositide 3-kinase (PI3K) catalytic subunit alpha polypeptide (PIK3CA) (p110-alpha) mutations from cell-free (cf) DNA in urine
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsMonitor metastatic colorectal cancer (mCRC) in patients undergoing therapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today